[1] |
Yip, W.C.M.; Hsiao, W.C.; Chen, W.; Hu, S.L.; Ma, J.; Maynard, A. Early appraisal of China's huge and complex health-care reforms. Lancet. 2012, 379, 833–842.
|
[2] |
Chen, Z. Launch of the health-care reform plan in China. Lancet. 2009, 373, 1322–1324.
|
[3] |
Klynveld Peat Marwick Goerdeler. Sanming: The Real Story of Grass-roots Healthcare Transformation in China; 2016.
|
[4] |
Ma, J. Discussion on the reform of public hospitals: case study on breakthrough of health reform in Sanming City. Heal. Econ. Res. 2014, 10, 34–36.
|
[5] |
Li, L. Public Hospital Reform Sanming model. Chin. J. News Rep. 2013, 9, 3840.
|
[6] |
Fu, H.Q.; Li, L.; Li, M.Q.; Yang, C.Y.; Hsiao, W. An evaluation of systemic reforms of public hospitals: the Sanming model in China. Health Policy Plan. 2017, 32, 1135–1145.
|
[7] |
He, Y.; Dou, G.; Huang, Q.; Zhang, X.; Ye, Y.; Qian, M.; Ying, X. Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study. PLoS One. 2018, 13, e0190320.
|
[8] |
Meng, Z.L.; Zhu, M.; Cai, Y.Y.; Cao, X.H.; Wu, H.Z. Effect of a typical systemic hospital reform on inpatient expenditure for rural population: the Sanming model in China. BMC Heal. Serv. Res. 2019, 19, 231.
|
[9] |
Ghei, P. How to investigate drug use in health facilities. Selected drug use indicators. Heal. Policy. 1995, 34, 73.
|
[10] |
The journal of global antimicrobial resistance meets the World Health Organization (WHO). J. Glob. Antimicrob. Resist. 2019, 18, 305–308.
|
[11] |
Fitchett, J.R.; Atun, R. Antimicrobial resistance: opportunity for Europe to establish global leadership. Lancet Infect. Dis. 2016, 16, 388–389.
|
[12] |
Qiao, M.; Ying, G.G.; Singer, A.C.; Zhu, Y.G. Review of antibiotic resistance in China and its environment. Environ. Int. 2018, 110, 160–172.
|
[13] |
Zhang, Z.T.; Hu, Y.H.; Zou, G.Y.; Lin, M.; Zeng, J.; Deng, S.M.; Zachariah, R.; Walley, J.; Tucker, J.D.; Wei, X.L. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob. Heal. Action. 2017, 10, 1287334.
|
[14] |
Li, Y. China’s misuse of antibiotics should be curbed. BMJ. 2014, 348, g1083.
|
[15] |
Holloway, K.A.; Ivanovska, V.; Wagner, A.K.; Vialle-Valentin, C.; Ross-Degnan, D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop. Med. Int. Heal. 2013, 18, 656–664.
|
[16] |
Shankar, P. Medicines use in primary care in developing and transitional countries: fact book summarizing results from studies reported between 1990 and 2006. Bull World Health Organ. 2009, 87, 804.
|
[17] |
World Health Organization. Safety of injections: Global facts and figures. Geneva: World Health Organization. 2004.
|
[18] |
Bairami, F.; Soleymani, F.; Rashidian, A. Improving injectable medicines prescription in outpatient services: a path towards rational use of medicines in Iran. Int. J. Health Policy Manag. 2016, 5, 321–324.
|
[19] |
Li, H.; Wang, S.; Yue, Z.; Ren, X.; Xia, J. Traditional Chinese herbal injection: Current status and future perspectives. Fitoterapia .2018, 129, 249–256.
|
[20] |
Liu, S.; Qiao, Y.; Liu, G.F. Adverse drug reactions of traditional Chinese medicine injections and irrational drug use. Central. South Pharm. 2016, 14, 1177–1182. (in Chinese)
|
[21] |
Principi, N.; Esposito, S. Antibiotic-related adverse events in paediatrics: unique characteristics. Expert. Opin. Drug Saf. 2019, 18, 795–802.
|